急性上消化道出血的内镜时机
该研究为随机对照试验,纳入有急性上消化道出血明显征象且Glasgow-Blatchford评分≥12分的患者,随机分为消化科会诊后6小时内行内镜(紧急内镜组)与6至24小时内行内镜(早期内镜组),主要终点为随机后30天内全因死亡。共516例患者入组,紧急内镜组30天死亡率为8.9%(23/258),早期内镜组为6.6%(17/258),差异为2.3个百分点(95%CI -2.3至6.9)。30天内再出血紧急内镜组28例(10.9%),早期内镜组20例(7.8%),差异3.1个百分点(95%CI -1.9至8.1)。结论认为在高危患者中,消化科会诊后6小时内行内镜并未较6至24小时内行内镜降低30天死亡率。
要点
- 高危急性上消化道出血患者(Glasgow-Blatchford评分≥12分)在消化科会诊后6小时内行内镜,30天死亡率为8.9%(23/258),而6至24小时内行内镜为6.6%(17/258),差异2.3个百分点(95%CI -2.3至6.9),未达统计学显著。
- 30天内再出血在紧急内镜组为10.9%(28/258),早期内镜组为7.8%(20/258),差异3.1个百分点(95%CI -1.9至8.1),未达统计学显著。
- 首次内镜发现消化性溃疡伴活动性出血或可见血管者,紧急内镜组为66.4%(105/158),早期内镜组为47.8%(76/159)。
- 首次内镜接受内镜下止血治疗者,紧急内镜组为60.1%(155/258),早期内镜组为48.4%(125/258)。
适用人群与场景
- 有急性上消化道出血明显征象且Glasgow-Blatchford评分≥12分(评分范围0至23分,分值越高再出血或死亡风险越高)的患者。
诊断标准与关键阈值
- Glasgow-Blatchford评分≥12分作为纳入高危患者的阈值。
处置流程与药物剂量
- 消化科会诊后6小时内行内镜(紧急内镜组)。
- 消化科会诊后6至24小时内行内镜(早期内镜组)。
研究设计与关键结果
- 研究为随机对照试验,共纳入516例患者,随机分为消化科会诊后6小时内行内镜组(紧急内镜组)与6至24小时内行内镜组(早期内镜组),主要终点为随机后30天内全因死亡。
- 30天死亡率:紧急内镜组8.9%(23/258)vs 早期内镜组6.6%(17/258),差异2.3个百分点(95%CI -2.3至6.9)。
- 30天内再出血:紧急内镜组10.9%(28/258)vs 早期内镜组7.8%(20/258),差异3.1个百分点(95%CI -1.9至8.1)。
- 首次内镜发现消化性溃疡伴活动性出血或可见血管:紧急内镜组66.4%(105/158)vs 早期内镜组47.8%(76/159)。
- 首次内镜接受内镜下止血治疗:紧急内镜组60.1%(155/258)vs 早期内镜组48.4%(125/258)。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于Glasgow-Blatchford评分≥12分的急性上消化道出血高危患者,消化科会诊后6小时内行内镜并未较6至24小时内行内镜降低30天死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: It is recommended that patients with acute upper gastrointestinal bleeding undergo endoscopy within 24 hours after gastroenterologic consultation. The role of endoscopy performed within time frames shorter than 24 hours has not been adequately defined.
METHODS: To evaluate whether urgent endoscopy improves outcomes in patients predicted to be at high risk for further bleeding or death, we randomly assigned patients with overt signs of acute upper gastrointestinal bleeding and a Glasgow-Blatchford score of 12 or higher (scores range from 0 to 23, with higher scores indicating a higher risk of further bleeding or death) to undergo endoscopy within 6 hours (urgent-endoscopy group) or between 6 and 24 hours (early-endoscopy group) after gastroenterologic consultation. The primary end point was death from any cause within 30 days after randomization.
RESULTS: A total of 516 patients were enrolled. The 30-day mortality was 8.9% (23 of 258 patients) in the urgent-endoscopy group and 6.6% (17 of 258) in the early-endoscopy group (difference, 2.3 percentage points; 95% confidence interval [CI], -2.3 to 6.9). Further bleeding within 30 days occurred in 28 patients (10.9%) in the urgent-endoscopy group and in 20 (7.8%) in the early-endoscopy group (difference, 3.1 percentage points; 95% CI, -1.9 to 8.1). Ulcers with active bleeding or visible vessels were found on initial endoscopy in 105 of the 158 patients (66.4%) with peptic ulcers in the urgent-endoscopy group and in 76 of 159 (47.8%) in the early-endoscopy group. Endoscopic hemostatic treatment was administered at initial endoscopy for 155 patients (60.1%) in the urgent-endoscopy group and for 125 (48.4%) in the early-endoscopy group.
CONCLUSIONS: In patients with acute upper gastrointestinal bleeding who were at high risk for further bleeding or death, endoscopy performed within 6 hours after gastroenterologic consultation was not associated with lower 30-day mortality than endoscopy performed between 6 and 24 hours after consultation. (Funded by the Health and Medical Fund of the Food and Health Bureau, Government of Hong Kong Special Administrative Region; ClinicalTrials.gov number, NCT01675856.).
参考来源
- Lau JYW, Yu Y, Tang RSY, et al. Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding. N Engl J Med. 2020. PMID: 32242355. doi:10.1056/NEJMoa1912484
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。